Gianni Paoletta
Freelance Medical Writer
I am a freelance Medical Writer with over 20 years of experience in international communication agencies. I have worked for numerous pharmaceutical brands in many therapeutic areas (in particular, diabetes, respiratory diseases, rheumatology and oncology).
Who I am
I can discuss complex medical topics with the style and depth most appropriate for different interlocutors, such as doctors, patients, and pharmacists. In addition, I possess in-depth knowledge of web and digital communication.
Torna in altoWhat I do
Promotional materials for pharmaceutical marketing
- eDetailings
- Visual aids
- Leaflets
- Brochures
- Websites
- Slide kits
- Disease awareness campaigns for physicians or patients
Medical communication
- Manuscripts for peer-reviewed journals
- Reviews
- Posters
- Abstracts
- Slide kits
Events
- Congress reports
- Workshops
- Advisory boards
Translations
- From English to Italian
- Adaptation of global materials compliant with Italian regulations
Portfolio
Below are some of the articles for which I provided Medical Writing support (click to download).
SOLE Study Group. Translation and initial validation of the Medication Adherence Report Scale (MARS) in Italian patients with Crohn's Disease. Dig Liver Dis. 2019 May;51(5):640-647.
Berra C, et al. AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus. Acta Diabetol. 2023 Sep;60(9):1257-1266.
Briatico G, et al. Real-World Experience With Topical 5-Fluorouracil 4% (40 mg/g) Cream for the Treatment of Actinic Keratosis. Dermatol Pract Concept. 2023 Apr 1;13(2):e2023151.
Malapelle U, et al. Detecting BRAF mutations in colorectal cancer in clinical practice: An Italian experts' position paper. Crit Rev Oncol Hematol. 2025 Feb;206:104574.
Antonioli L, et al. JAK inhibitors: an evidence-based choice of the most appropriate molecule. Front Pharmacol. 2024 Oct 29;15:1494901.
De Corso E, et al. Chronic Rhinosinusitis Optimisation of Nasal Outcomes and Scores (CHRONOS): An Italian Delphi Consensus on Long-Term Management with Biologics. Curr Allergy Asthma Rep. 2026 Jan 9;26(1):3.